期刊文献+

甲状腺功能异常对稳定性心绞痛患者发生心房颤动的影响 被引量:2

Association between thyroid dysfunction and incidence of atrial fibrillation in patients with stable angina
原文传递
导出
摘要 目的:观察甲状腺功能异常对稳定性心绞痛患者发生心房颤动(房颤)的影响。方法:纳入稳定性心绞痛患者617例为研究对象,根据患者血浆中促甲状腺激素(TSH)水平分成TSH〈0.55 m IU·L-1组、0.55~4.78 m IU·L-1组、〉4.78 m IU·L-1组。比较3组实验室检查的结果及各组房颤发生率。结果:617例稳定性心绞痛患者中,48例诊断为阵发性或持续性房颤,发生率为7.8%。房颤发生率TSH 0.55~4.78 m IU·L-1组最低,为6.3%(34/543);TSH〉4.78 m IU·L-1组最高,为19.6%(9/46),TSH〈0.55 m IU·L-1组为17.9%(5/28),3组之间差异有统计学意义(P=0.001)。相关性分析结果显示,甲状腺功能异常与稳定性心绞痛患者发生房颤存在相关性。结论:甲状腺功能异常与稳定性心绞痛患者房颤的发生相关,对合并甲状腺功能异常的稳定性心绞痛患者应警惕和预防房颤的发生。 Objective: To explore the correlation between thyroid dysfunction and incidence of atrial fibrillation( AF) in patients with stable angina. Methods: Six hundred and seventeen cases of stable angina were enrolled this research. According to TSH levels the patients were divided into 3 subgroups: 〈 0. 55 m IU ·L-1group,0. 55 ~4. 78 m IU·L-1group,〉 4. 78 m IU·L-1group. Laborlatery data and incidence of AF were compared among the three group. Results: A total of 48 patients were diagnosed as AF( 7. 8%). Incidence of AF in TSH 0. 55 ~ 4. 78 m IU· L-1group was the lowest( 6. 3%,34 /543); in TSH 〉 4. 78 m IU · L-1group was the highest( 19. 6%,9 /46),and in TSH 〈 0. 55 m IU · L-1group was 17. 9%( 5 /28),the difference among them was statistically significant( P = 0. 001). There was correlation between thyroid dysfunction and incidence of AF in patients with stable angina. Conclusion: Our results show correlation between thyroid dysfunction and incidence of AF in patients with stable angina. We should pay attention to preventing occurrence of AF in cases of stable angina with thyroid dysfunction.
出处 《现代医学》 2015年第9期1131-1133,共3页 Modern Medical Journal
关键词 稳定性心绞痛 甲状腺功能异常 心房颤动 危险因素 stable angina thyroid dysfunction atrial fibrillation risk factors
  • 相关文献

参考文献13

  • 1KARRAS S,TZOTZAS T, KALTSAS T, et al. Pharmacologicaltreatment of hyperthyroidism during lactation:review of the lit- erature and novel data [ J ]. Pediatr Endocrinol Rev, 2010,8 (1) :25-33.
  • 2GHANDOUR A, REUST C. Hyperthyroidism: a stepwise ap- proach to management [ J ]. J Faro Praet, 2011,60 ( 7 ) : 388- 395.
  • 3MANSOURIAN A R. A review of literature on the adverse effects of hyperthyroidism on the heart functional behavior [ J ]. Pak J Biol Sci ,2012,15 (4) : 164-176.
  • 4RAKHMATULLOV F K,KLIMOVA S V, RUDAKOVA L E,et al. The influence of subclinical thyroid dysfunction on cardiac hemodynamie and eleclmphysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation [ J]. Klin Med(Mosk) ,2012,90:31-34.
  • 5无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2065
  • 6LIP G Y,HALPERIN J L,TSE H F. The 2010 European Soci- ety of Cardiology Guidelines on the management of atrial fibril- lation: an evolution or revolution? I J ]. Chest, 2011,139 ( 8 ) : 738-741.
  • 7何森,王斯,陈晓平.心房颤动发病机制的研究进展[J].华西医学,2012,27(5):794-797. 被引量:20
  • 8PARK Y J, YOON J W, KIM K I, et al. Subclinical hypothy- roidism might increase the risk of transient atrial fibrillation af- ter coronary artery bypass grafting [ J ]. Ann Thorae Surg, 2009,87(13) :1846-1852.
  • 9BIONDI B, PALMIERI E A, LOMBARDI G, et al. Effects of subclinical thyroid dysfunction on the heart [ J ]. Ann Intern Med ,2002,137(10) :904-914.
  • 10STAVRAKIS S, YU X, PATI'ERSON E, et al. Activating autoantibodies to the beta-1 adrenergic and M2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism [ J ]. J Am Coil Cardiol, 2009,54 ( 14 ) : 1309-1316.

二级参考文献99

  • 1毛文文.甲状腺功能亢进性心脏病的预防和治疗[J].医学综述,2004,10(12):729-731. 被引量:7
  • 2刘灵芝,刘恒亮,武恩平.甲状腺功能亢进性心脏病32例临床分析[J].河南职工医学院学报,2006,18(2):111-113. 被引量:2
  • 3吴卫,柯丹,许春萱,邓玉莲,陈林,张建成,林亚洲,胡锡衷.Ⅰ型胶原和白细胞介素-1β在心房颤动患者心房中的表达[J].中华内科杂志,2006,45(10):807-810. 被引量:11
  • 4唐元升,朱兴雷.心房颤动治疗的新进展[J].中国实用内科杂志,1997,17(2):118-119. 被引量:8
  • 5Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 6Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 7Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 8Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 9O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 10Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.

共引文献2091

同被引文献23

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部